Boardroom Alpha
Boardroom Alpha
APD · Current Report (Form 8-K) · Filed August 20, 2025

Air Products & Chemicals Inc — Current Report (Form 8-K)

Form
8-K
Filed
August 20, 2025
Period
Aug 18, 2025
Ticker
APD
Accession
0001193125-25-183782
Boardroom Alpha · Filing insights

Air Products appoints Howard Ungerleider as an independent director, effective Sept 1, 2025, joining the Audit and Finance Committee.

About Air Products & Chemicals Inc
Market cap
$62.2B
1Y TSR
+7.8%
3Y TSR
+3.5%
Board grade
C
Sector
Basic Materials
CEO
Eduardo F Menezes
Last annual meeting: Jan 28, 2026 · View full Air Products & Chemicals Inc profile →
8-K
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) August 18, 2025

 

 

Air Products and Chemicals, Inc.

(Exact name of registrant as specified in charter)

 

 

 

Delaware   001-04534   23-1274455

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

1940 Air Products Boulevard Allentown,

Pennsylvania 18106-5500

(Address of principal executive offices and Zip Code)

(610) 481-4911

Registrant’s telephone number, including area code

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, par value $1.00 per share   APD   New York Stock Exchange
0.500% Euro Notes due 2028   APD28   New York Stock Exchange
2.950% Euro Notes due 2031   APD31   New York Stock Exchange
0.800% Euro Notes due 2032   APD32   New York Stock Exchange
3.250% Euro Notes due 2032   APD32B   New York Stock Exchange
4.000% Euro Notes due 2035   APD35   New York Stock Exchange
3.450% Euro Notes due 2037   APD37   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 under the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 under the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 18, 2025, the board of directors (the “Board”) of Air Products and Chemicals, Inc. (the “Company”) elected Howard Ungerleider as a director of the Company, effective September 1, 2025. Mr. Ungerleider, 56, is an Operating Advisor at Clayton, Dubilier & Rice, a leading private equity firm, and previously served from 2018 to 2023 as President and from 2014 to 2023 as Chief Financial Officer of Dow Inc. and its predecessors.

In connection with Mr. Ungerleider’s election, the Board considered his independence under New York Stock Exchange listing standards and the Company’s Corporate Governance Guidelines and concluded that he will be an independent director under these standards. The Board assigned Mr. Ungerleider to serve as a member of its Audit and Finance Committee, also effective September 1, 2025.

Mr. Ungerleider will receive compensation and be subject to indemnification for serving as a member of the Board consistent with the Company’s normal arrangements for non-employee directors, which are described in the Company’s definitive proxy statement for its 2025 annual meeting of shareholders. There are no arrangements or understandings between Mr. Ungerleider and any other person pursuant to which Mr. Ungerleider was elected as a director, and neither Mr. Ungerleider nor any of his immediate family members is a party, either directly or indirectly, to any transaction that would be required to be reported under Item 404(a) of Regulation S-K.

A copy of the Company’s press release announcing the election of Mr. Ungerleider is filed as Exhibit 99.1 hereto and is incorporated herein by reference.

 

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit No.   

Description

99.1    Press Release dated August 20, 2025.
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Air Products and Chemicals, Inc.
  (Registrant)
Date: August 20, 2025     By:  

/s/ Matthew Lepore

      Matthew Lepore
      Executive Vice President,
      General Counsel and Secretary
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Air Products & Chemicals Inc (APD)

Reference

Frequently asked questions

When did Air Products & Chemicals Inc file this 8-K?
Air Products & Chemicals Inc (APD) filed this Current Report (Form 8-K) with the SEC on August 20, 2025. The accession number assigned by EDGAR is 0001193125-25-183782.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Air Products appoints Howard Ungerleider as an independent director, effective Sept 1, 2025, joining the Audit and Finance Committee. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Air Products & Chemicals Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Air Products & Chemicals Inc has filed under CIK 2969, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer